Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-19 02:39:14 UTC |
---|
Update Date | 2016-11-09 01:13:44 UTC |
---|
Accession Number | CHEM008140 |
---|
Identification |
---|
Common Name | 2-Hydroxyestradiol |
---|
Class | Small Molecule |
---|
Description | A 2-hydroxy steroid that consists of 17beta-estradiol having an additional hydroxy group at position 2. |
---|
Contaminant Sources | - FooDB Chemicals
- HMDB Contaminants - Urine
- My Exposome Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
(17beta)-Estra-1,3,5(10)-triene-2,3,17-triol | ChEBI | 2-Hydroxyestradiol-17beta | ChEBI | 2-OH-e2 | ChEBI | 2-OH-Estradiol | ChEBI | (17b)-Estra-1,3,5(10)-triene-2,3,17-triol | Generator | (17Β)-estra-1,3,5(10)-triene-2,3,17-triol | Generator | 2-Hydroxyestradiol-17b | Generator | 2-Hydroxyestradiol-17β | Generator | (17b)-Estra-1,3, 5(10)-triene-2,3,17-triol | HMDB | (17beta)- Estra-1,3, 5 (10)-triene-2,3,17-triol | HMDB | 1,3,5(10)-Estratriene-2,3,17Beta-triol | HMDB | 17beta-2-Hydroxyestradiol | HMDB | 2,3,17b-Trihydroxyestra-1,3,5(10)-triene | HMDB | 2-Hydroxy-17beta-estradiol | HMDB | 2-Hydroxy-estradiol | HMDB | ECS | HMDB | Estra-1,3,5 (10)-triene-2,3,17.beta.-triol | HMDB | Estra-1,3,5(10)-triene-2,3,17-beta-triol | HMDB | Estra-1,3,5(10)-triene-2,3,17-triol (acd/name 4.0) | HMDB | Estra-1,3,5(10)-triene-2,3,17b-triol | HMDB | Estra-1,3,5(10)-triene-2,3,17beta-triol | HMDB | 2-Hydroxyestradiol-17 alpha | HMDB | 2-Hydroxyestradiol-17 beta | HMDB | 2-Hydroxyestradiol, (17alpha)-isomer | HMDB | 2-Hydroxyestradiol, 4-(14)C-labeled | HMDB |
|
---|
Chemical Formula | C18H24O3 |
---|
Average Molecular Mass | 288.381 g/mol |
---|
Monoisotopic Mass | 288.173 g/mol |
---|
CAS Registry Number | 362-05-0 |
---|
IUPAC Name | (1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-4,5,14-triol |
---|
Traditional Name | (1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-4,5,14-triol |
---|
SMILES | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(O)=C3 |
---|
InChI Identifier | InChI=1S/C18H24O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,17,19-21H,2-7H2,1H3/t11-,12+,14-,17-,18-/m0/s1 |
---|
InChI Key | DILDHNKDVHLEQB-XSSYPUMDSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Estrane steroids |
---|
Direct Parent | Estrogens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Estrogen-skeleton
- 3-hydroxysteroid
- 2-hydroxysteroid
- Hydroxysteroid
- 17-hydroxysteroid
- Phenanthrene
- Tetralin
- 1-hydroxy-2-unsubstituted benzenoid
- Benzenoid
- Cyclic alcohol
- Secondary alcohol
- Polyol
- Organooxygen compound
- Alcohol
- Hydrocarbon derivative
- Organic oxygen compound
- Aromatic homopolycyclic compound
|
---|
Molecular Framework | Aromatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0adr-2490000000-7e8a9e3990faceb5f6d0 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (3 TMS) - 70eV, Positive | splash10-002u-1002900000-79ac7707883246949511 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_1_1) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_1_2) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_1_3) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_2_1) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_2_2) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_2_3) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-00ei-2950000000-326e2d3fee4fb8b3ca6c | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-00di-2910000000-553a7988f4c2019ec5d5 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-0f96-8975000000-eef1fcf44ed6a27f53a9 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00dr-0190000000-0e1c17e32d9c1e4063eb | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00dr-0790000000-01416dcd9eea3747d3c5 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-6970000000-d27a7add654c423ec534 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0090000000-805faf5743eec20547cb | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-0090000000-c39e06f8fdeeb111e97f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0596-1190000000-36538cb7b1a03d7b2ff7 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0090000000-572916cfebc6538c52d0 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-01w0-0490000000-7a41b9ec75d4c7c28c73 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-004j-3910000000-4dd2fe1697c6e685073e | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0090000000-843a74fabb1d0eb512a1 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-0090000000-40c60966bb1ce4624953 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-1009-0090000000-1c821729dedb3f0fecbe | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 2D NMR | [1H,13C] 2D NMR Spectrum | Not Available | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB07706 |
---|
HMDB ID | HMDB0000338 |
---|
FooDB ID | FDB021962 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | 5327 |
---|
PDB ID | Not Available |
---|
Wikipedia Link | 2-Hydroxyestradiol |
---|
Chemspider ID | 216475 |
---|
ChEBI ID | 28744 |
---|
PubChem Compound ID | 247304 |
---|
Kegg Compound ID | C05301 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. https://www.ncbi.nlm.nih.gov/pubmed/?term=11812141 | 2. https://www.ncbi.nlm.nih.gov/pubmed/?term=14563383 | 3. https://www.ncbi.nlm.nih.gov/pubmed/?term=14872091 | 4. https://www.ncbi.nlm.nih.gov/pubmed/?term=15662657 | 5. https://www.ncbi.nlm.nih.gov/pubmed/?term=16404153 | 6. https://www.ncbi.nlm.nih.gov/pubmed/?term=16421288 | 7. https://www.ncbi.nlm.nih.gov/pubmed/?term=16788039 | 8. Kiuru, Paula S.; Wahala, Kristiina. Short synthesis of 2-methoxyestradiol and 2-hydroxyestradiol. Steroids (2003), 68(4), 373-375. | 9. Takanashi K, Honma T, Kashiwagi T, Honjo H, Yoshizawa I: Detection and measurement of urinary 2-hydroxyestradiol 17-sulfate, a potential placental antioxidant during pregnancy. Clin Chem. 2000 Mar;46(3):373-8. | 10. Elce JS, Bird CE, Chandra J: Water-soluble products of the estrogens. Bile metabolites of 2-hydroxyestradiol-17beta in man. J Clin Endocrinol Metab. 1973 May;36(5):1027-30. | 11. Zhu BT, Conney AH: Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998 Jan;19(1):1-27. | 12. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997 Mar;138(3):863-70. | 13. Schaeffer JM, Hsueh AJ: 2-Hydroxyestradiol interaction with dopamine receptor binding in rat anterior pituitary. J Biol Chem. 1979 Jul 10;254(13):5606-8. |
|
---|